India Medical Device Market: 2015-2018
August 5, 2015 | Business WireEstimated reading time: 1 minute
Research and Markets has announced the addition of the "The Medical Device Market: India" report to their offering.
India has the third largest GDP in Asia, behind China and Japan. Per capita GDP remains relatively low, however, at around US$1,488 in 2013. Economic growth hit a decade-low of 5.0% in 2012, but growth rates are expected to gradually pick up reaching 5.5% in 2013 and 6.0% in 2014. The forecasting average real GDP expansion of 6.4% per annum over the next five years, driven, ultimately, by the Indian consumer. However, per capita income will remain less than a third that of China's at US$2,435 in 2018.
The private sector is the dominant healthcare provider, particularly in urban areas, and as such is the major end-user of medical equipment. High quality, high tech products are sought after, particularly by facilities run by corporate groups such as Apollo Hospitals and Fortis Healthcare. An estimated 95% of all new hospital beds created in recent years have been in the private sector and future increased demand for medical equipment and supplies is likely to continue to come mainly from private sector hospitals and medical centres.
Health insurance uptake remains low; private health insurance funds less than 5.0% of private health spending and only around 3.2% of total health expenditure. Since 2008, the government has funded a scheme to provide health insurance coverage for the very poor, which currently covers around 32mn families.
Detailed regulation of medical devices remains a work in progress. To date a number of implantable and sterile medical devices have been added to the Drugs and Cosmetics Act, bringing them into regulatory control and new guidelines for sterile medical devices came into force on 1st March 2006. The government has been working on the revision of rules in recognition of the need to consider medical devices as a separate category. The new regulations were to have been published as the Drugs, Cosmetics and Medical Device bill in the winter 2012 parliamentary session, but doubt remains over the future of the bill amidst reports that it does not meet the requirements of the medical device industry in its present form. In the meantime, the medical device industry has called on the government to come up with an interim regulatory mechanism in the form of a guidance document.
Testimonial
"Our marketing partnership with I-Connect007 is already delivering. Just a day after our press release went live, we received a direct inquiry about our updated products!"
Rachael Temple - AlltematedSuggested Items
Electra’s ElectraJet EMJ110 Inkjet Soldermask Now in Black & Blue at Sunrise Electronics
09/08/2025 | Electra Polymers LtdFollowing the successful deployment of Electra’s Green EMJ110 Inkjet Soldermask on KLA’s Orbotech Neos™ platform at Sunrise Electronics in Elk Grove Village, Illinois, production has now moved beyond green.
Magnachip Semiconductor Announces YJ Kim to Step Down as CEO; Current Board Chairman Camillo Martino Appointed Interim CEO
08/14/2025 | PR NewswireMagnachip Semiconductor Corporation today announced that YJ Kim has agreed to step down as CEO and as a member of the Board of Directors, effective immediately. Camillo Martino, Chairman of the Board of Directors, has also been appointed Interim Chief Executive Officer, effective immediately.
Bell to Build X-Plane for Phase 2 of DARPA Speed and Runway Independent Technologies (SPRINT) X-Plane Program
07/09/2025 | Bell Textron Inc.Bell Textron Inc., a Textron Inc. company, has been down-selected for Phase 2 of Defense Advanced Research Projects Agency (DARPA) Speed and Runway Independent Technologies (SPRINT) X-Plane program with the objective to complete design, construction, ground testing and certification of an X-plane demonstrator.
Nolan’s Notes: Moving Forward With Confidence
06/03/2025 | Nolan Johnson -- Column: Nolan's NotesWe’re currently enjoying a revitalized and dynamic EMS provider market with significant growth potential. Since December 2024, the book-to-bill has been extremely strong and growing. Starting with a ratio of 1.24 in December, book-to-bill has continued to accelerate to a 1.41 in April. Yet, there is a global economic restructuring taking place. To say that the back-and-forth with tariffs and trade deals makes for an uncertain market is an understatement. While we may be in a 90-day tariff pause among leading economic nations, the deadline is quickly approaching and that leaves many of you feeling unsettled about what to expect.
Mycronic High Flex Changes Division Name to PCB Assembly Solutions
05/20/2025 | MycronicMycronic AB, the leading Sweden-based electronics assembly solutions provider, announced that its division formerly known as High Flex will now operate under the name PCB Assembly Solutions.